Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Don`t focus on market cap!

Don`t focus on market cap!

posted on Mar 02, 2006 11:09AM
This stock is going to write a new chapter in trading history. We need the share float. Because I believe the vol shows there really are not alot of shares outstanding to trade. Just look at SIRI and a ton of other money loosing dogs on the Nasdaq that never have nor ever will make a profit. Our share price will go alot higher based on (EARNINGS) AND (PROFITS) and A (DIVIDEND) Earnings are nothing more then recorded sales. The most important thing is what the net profit is. Also we have no (debt). And really very little over head. What more do you want. If we do a 100mill in lic. almost 90% of that is profit. They say the market is now 260bill. if you could get 1% of that as a trading indicator .your talking about a possible market cap of 23bill per year to trade on. you could argue that TPL gets half so say 13bill market cap thats still a very hefty P/S. I`m waiting for the Qrtly numbers they should be off the wall QRT over QRT.

Leck. keeps repeating systems companies pay royality we will see if the early birds do.

JMHO

Share
New Message
Please login to post a reply